Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > 1次抗体

Anti-Human HLA-A2 Recombinant Antibody (3PF12) (HM833013)

Anti-Human HLA-A2 Recombinant Antibody (3PF12)
Anti-Human HLA-A2 Recombinant Antibody (3PF12)
価格(USD):
スペック:
  • 20ug
  • 50ug
  • 100ug
  • 1mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HM833013
種反応性Human
アプリケーションELISA, FCM
宿主種Mouse
クローン性Monoclonal
アイソタイプIgG1
クローンID3PF12
ターゲット HLAA, Human leukocyte antigen A, HLA class I histocompatibility antigen, A alpha chain, HLA-A
エンドトキシンレベル Please contact with the lab for this information.
純度 >95% as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 P04439
RRID

Anti-Human HLA-A2 Antibody (3PF12) (abinScience Cat# HM833013, RRID:AB_3727811)
_x005F_x005F_x000D_

形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

製品使用情報
アプリケーション 希釈
ELISA 1:2000-1:20000
安定性と保存 Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
背景

HLA class I histocompatibility antigen, A alpha chain (HLA-A2) is a ~40 kDa protein. Antigen-presenting major histocompatibility complex class I (MHCI) molecule. In complex with B2M/beta 2 microglobulin displays primarily viral and tumor-derived peptides on antigen-presenting cells for recognition by alpha-beta T cell receptor (TCR) on HLA-A-restricted CD8-positive T cells, guiding antigen-specific T cell immune response to eliminate infected or transformed cells. May also present self-peptides derived from the signal sequence of secreted or membrane proteins, although T cells specific for these peptides are usually inactivated to prevent autoreactivity. Both the peptide and the MHC molecule are recognized by TCR, the peptide is responsible for the fine specificity of antigen recognition and MHC residues account for the MHC restriction of T cells. Typically presents intracellular peptide antigens of 8 to 13 amino acids that arise from cytosolic proteolysis via IFNG-induced immunoproteasome or via endopeptidase IDE/insulin-degrading enzyme.

1. Fukada, K. et al. (1999) AIDS (London, England) 13, 1413-4. PMID: 10449296
2. Nagata, Y. et al. (2002) Proceedings of the National Academy of Sciences of the United States of America 99, 10629-34. PMID: 12138174
3. Kuzushima, K. et al. (2003) Blood 101, 1460-8. PMID: 12393434
4. Traversari, C. et al. (1992) The Journal of experimental medicine 176, 1453-7. PMID: 1402688
5. Satoh, M. et al. (2005) Vaccine 23, 3783-90. PMID: 15893615
6. Asemissen, AM. et al. (2006) Clinical cancer research : an official journal of the American Association for Cancer Research 12, 7476-82. PMID: 17189421
7. Hadrup, SR. et al. (2009) Nature methods 6, 520-6. PMID: 19543285
8. Matthews, PC. et al. (2011) Journal of immunology (Baltimore, Md. : 1950) 186, 5675-86. PMID: 21498667
9. Shimizu, A. et al. (2013) Scientific reports 3, 3097. PMID: 24192765
10. Quiñones-Parra, S. et al. (2014) Proceedings of the National Academy of Sciences of the United States of America 111, 1049-54. PMID: 24395804
注意事項 For research use only.
イメージ
  • Anti-Human HLA-A2 Recombinant Antibody (3PF12)

    SDS-PAGE

    SDS-PAGE for Anti-Human HLA-A2 Antibody (3PF12).

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト